Working group
Clinical management, epidemiology and immunology of newly emerging infections
Short description
This research group, led by Professor Marylyn Addo, initiates and coordinates translational research in the field of emerging infections with a particular focus on Ebola, MERS, Lassa and Crimean-Congo haemorrhagic fever. Immunology studies, vaccine development, testing of novel anti-infectives and outbreak management are at the core of their studies. For example, the group was involved in developing an Ebola vaccine which is now being tested further in Africa. A clinical trial investigating a new MERS vaccine is currently being conducted. A group led by Munoz-Fontela uses animal models and conducts clinical trials in Africa to understand the physiology of immune responses to these viruses.
Research areas
Institutions
Partner Sites
Contact person